Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Long-Term Debt Repayments (2016 - 2019)

Historic Long-Term Debt Repayments for Altimmune (ALT) over the last 6 years, with Q4 2019 value amounting to $105062.0.

  • Altimmune's Long-Term Debt Repayments changed N/A to $105062.0 in Q4 2019 from the same period last year, while for Dec 2020 it was $135857.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $632000.0 for FY2020, which is 11643.69% up from last year.
  • Per Altimmune's latest filing, its Long-Term Debt Repayments stood at $105062.0 for Q4 2019.
  • In the past 5 years, Altimmune's Long-Term Debt Repayments registered a high of $105062.0 during Q4 2019, and its lowest value of -$250009.0 during Q3 2015.
  • Over the past 3 years, Altimmune's median Long-Term Debt Repayments value was $99.0 (recorded in 2016), while the average stood at -$76150.3.
  • In the last 5 years, Altimmune's Long-Term Debt Repayments fell by 0.4% in 2015 and then soared by 10003.96% in 2016.
  • Altimmune's Long-Term Debt Repayments (Quarter) stood at -$250009.0 in 2015, then soared by 132.4% to $80999.0 in 2016, then increased by 29.71% to $105062.0 in 2019.
  • Its Long-Term Debt Repayments was $105062.0 in Q4 2019, compared to $30795.0 in Q3 2019 and $80999.0 in Q4 2016.